3-NONANON-1-YL ACETATE
General Information
Mainterm | 3-NONANON-1-YL ACETATE |
Doc Type | NIL |
CAS Reg.No.(or other ID) | 7779-54-6 |
Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 12678469 |
IUPAC Name | 3-oxononyl acetate |
InChI | InChI=1S/C11H20O3/c1-3-4-5-6-7-11(13)8-9-14-10(2)12/h3-9H2,1-2H3 |
InChI Key | SIDKXKCKKVBGMY-UHFFFAOYSA-N |
Canonical SMILES | CCCCCCC(=O)CCOC(=O)C |
Molecular Formula | C11H20O3 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 200.278 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 9 |
Complexity | 175.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A C A S g g A I C C A A A B A A I A I C Q C A A A A A A A A A A A A A E A A A A A A B Y A A A A C A A A E I A A A A A G I y K C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 43.4 |
Monoisotopic Mass | 200.141 |
Exact Mass | 200.141 |
XLogP3 | None |
XLogP3-AA | 2.2 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 14 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9825 |
Human Intestinal Absorption | HIA+ | 0.9936 |
Caco-2 Permeability | Caco2+ | 0.6957 |
P-glycoprotein Substrate | Non-substrate | 0.6592 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7750 |
Non-inhibitor | 0.7411 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8612 |
Distribution | ||
Subcellular localization | Mitochondria | 0.8412 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8943 |
CYP450 2D6 Substrate | Non-substrate | 0.8875 |
CYP450 3A4 Substrate | Non-substrate | 0.6296 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6631 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8665 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9146 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8692 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9213 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8209 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9243 |
Non-inhibitor | 0.8592 | |
AMES Toxicity | Non AMES toxic | 0.9673 |
Carcinogens | Carcinogens | 0.5255 |
Fish Toxicity | High FHMT | 0.8636 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9764 |
Honey Bee Toxicity | High HBT | 0.7292 |
Biodegradation | Ready biodegradable | 0.9611 |
Acute Oral Toxicity | II | 0.5356 |
Carcinogenicity (Three-class) | Non-required | 0.6064 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.3348 | LogS |
Caco-2 Permeability | 0.8988 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.8227 | LD50, mol/kg |
Fish Toxicity | 0.6669 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.6238 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohol esters |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohol esters |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol ester - Ketone - Carboxylic acid ester - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohol esters. These are ester derivatives of a fatty alcohol. |
From ClassyFire